Previous Close | 0.0000 |
Open | 0.0605 |
Bid | 0.0017 x 0 |
Ask | 0.2400 x 0 |
Day's Range | 0.0605 - 0.0605 |
52 Week Range | 0.0015 - 0.9999 |
Volume | |
Avg. Volume | 2,522 |
Market Cap | 3.63M |
Beta (5Y Monthly) | 0.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1200 |
Earnings Date | Nov 18, 2024 - Nov 19, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TORONTO, ON / ACCESSWIRE / July 9, 2024 /StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene expression multi-cancer diagnostic for screening for ...
TORONTO, ON / ACCESSWIRE / May 23, 2024 /StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers ...